Event Abstract

Novel method for synthesis of multiphase bioactive glass ceramic powder in the CaO-MgO-SiO2 system

  • 1 Nuclear and Energy Research Institute, Materials Science and Technology Center, Brazil
  • 2 Federal University of ABC, Biomedical Engineering, Brazil
  • 3 Nuclear and Energy Research Institute, Biology Center, Brazil

Introduction: CaO-MgO-SiO2 system bioceramics show superior mechanical properties compared to other typical bioceramics such as calcium phosphates [1]. Studies have shown the excellent bioactivity (hydroxyapatite (HA) formation) of some Ca and Mg content silicate ceramics, such as wollastonite, diopside and akermanite. These materials can promote cell adhesion, proliferation, spreading, and differentiation, exhibiting various advantages for bone regeneration. Studies of the CaO-MgO-SiO2 system for biomedical application are an emerging area of biomaterial technology [2]. In this work CaO-MgO-SiO2 glass-ceramic powder was synthesized by a novel method: Ca and Mg were precipitated on SiO2 gel obtained from Na2SiO3. The glass-ceramic sintered at 1300 οC presented Wollastonite and akermanite bioactive phases. No toxicity was found in the cytotoxicity test with CHO (Chinese hamster ovary) cells. XRD, SEM (Scanning electron microscopy) and FTIR (Fourier Transform Infrared) investigations were conducted for bioactivity test by soaking the material in Simulated Body Fluid (SBF). 

Materials and Methods: CaO-MgO-SiO2 glass ceramic was prepared by a new proposed method. In vitro cytotoxicity was performed with CHO-k1 as recommended by ISO 10993 [3]. In order to estimate the in-vitro bioactivity of the samples the SBF proposed by Kokubo et al. [4] was used for 7, 14 and 21 days. The experimental procedure is showed in Fig. 1.

Results and Discussion: Peaks of bioactive silicate ceramics; wollastonite, akermanite and dicalcium silicate were detected by XRD, in the ceramic of CaO-MgO-SiO2. FTIR spectra of the ceramic surface, after bioactivity test performed by soaking the samples in SBF for  7, 14 and 21 days showed phosphate characteristic absorption band at about 1034 cm-1, indicating the formation of HA. Fig.2 shows SEM micrographs of the glass-ceramic before (a) and after 14 days soaking in SBF (b).  In Fig. 2(a) a continuously connected crystalline grains with open pores microstructure of sintered body is observed. In Fig. 2(b), particles with microspheres morphology [4] uniformly deposited on the surface are seen, confirm the presence of HA. According to ISO 10993-5, the cytotoxicity test revealed that the glass-ceramic did not show cytotoxicity.

Conclusion: A new method sol gel technique combined to precipitation, for preparing CaO-MgO-SiO2  powder  was  presented. A glass-ceramic with bioactive crystalline phases: wollastonite, akermanite and dicalcium silicate were  obtained. According to ISO 10993-5, the material can be considered non cytotoxic. The bioactivity test of glass-ceramic reveled that, after 7 days soaking of the sample in SBF,  HA was detected on the surface.

FAPESP- SÃO PAULO RESEARCH FUNDATION

References:
[1] M. Diba, et all, Curr. Opin. Solid St. Mat. Sci., 18, 2014, 147-167.
[2] S. Ni, et all, J. Mater. Sci. Mater. Med., 19, 2008, 359-367.
[3] Rodas, A. C. M., et all, Artif. Organs. 32, 4, 272-276.
[4] T. Kokubo, et all, J. Biomed. Mater. Res., 24, 1990, 721-734.

Keywords: Tissue Engineering, biomaterial, Bioactivity, Precursor

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Biomaterials in constructing tissue substitutes

Citation: Yamagata C, Rodrigues VG, Rodas AD and Z. Higa O (2016). Novel method for synthesis of multiphase bioactive glass ceramic powder in the CaO-MgO-SiO2 system. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01200

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.